- Home
- BMR vs SER Comparison
BMR vs SER Comparison
Compare BMR & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMR
- SER
- Stock Information
- Founded
- BMR 2009
- SER 2017
- Country
- BMR Israel
- SER United States
- Employees
- BMR N/A
- SER N/A
- Industry
- BMR Computer Software: Prepackaged Software
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- BMR Technology
- SER Health Care
- Exchange
- BMR Nasdaq
- SER Nasdaq
- Market Cap
- BMR 51.2M
- SER 54.3M
- IPO Year
- BMR 2023
- SER 2018
- Fundamental
- Price
- BMR $2.61
- SER $4.83
- Analyst Decision
- BMR
- SER
- Analyst Count
- BMR 0
- SER 0
- Target Price
- BMR N/A
- SER N/A
- AVG Volume (30 Days)
- BMR 161.7K
- SER 17.4K
- Earning Date
- BMR 11-30-2024
- SER 11-12-2024
- Dividend Yield
- BMR N/A
- SER N/A
- EPS Growth
- BMR N/A
- SER N/A
- EPS
- BMR N/A
- SER N/A
- Revenue
- BMR $2,955,000.00
- SER $3,156,637.00
- Revenue This Year
- BMR $21.52
- SER N/A
- Revenue Next Year
- BMR N/A
- SER N/A
- P/E Ratio
- BMR N/A
- SER N/A
- Revenue Growth
- BMR 2.25
- SER 2436.14
- 52 Week Low
- BMR $1.11
- SER $3.81
- 52 Week High
- BMR $34.94
- SER $19.93
- Technical
- Relative Strength Index (RSI)
- BMR 30.94
- SER 33.74
- Support Level
- BMR $2.50
- SER $3.81
- Resistance Level
- BMR $3.03
- SER $5.79
- Average True Range (ATR)
- BMR 0.22
- SER 0.79
- MACD
- BMR -0.03
- SER -0.13
- Stochastic Oscillator
- BMR 10.68
- SER 25.89
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.